PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

A most comprehensive exploratory study..., page-10

  1. 4,178 Posts.
    lightbulb Created with Sketch. 6655
    Appreciate the feedback, it does encourage me to read and write more.



    Oakky67 - Could say a whole heap more on each biomarker...each one could easily be a large post in itself.
    When I go full time (not if, when !!) on this research, that's when we can break them down properly.

    Out of all the ones, it appears CTX II is one of the most prognostic ones in terms of OA progression, but PAR are smart, they ain't just concentrating on one such marker, they are spanning over the groups of markers...

    They are covering also both of the main groups, hence my little excel table to give you an idea...both sets, bio chemical and structural.

    Imagine how happy our teacher (FDA/EMA) are going to be when we hand in our assignment...particularly if iPPS shows how good she is as an effective, efficacious and SAFE molecule.



    Watch this space
    Last edited by Mozzarc: 24/07/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.015(5.36%)
Mkt cap ! $103.1M
Open High Low Value Volume
28.0¢ 29.5¢ 28.0¢ $70.41K 247.5K

Buyers (Bids)

No. Vol. Price($)
1 36155 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 8388 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.